2022 the Japanese Society of Medical Oncology Annual Meeting

Session information

Mini-Oral Session

[MO10] Mini-Oral Session 10 Hematologic Malignancies 1(Myeloid)
【E】

Thu. Feb 17, 2022 2:45 PM - 3:45 PM Room 7 (Room E, 1F, Kyoto International Conference Center)

Chair:Shigeki Ito(Department of Hematology & Oncology, Iwate Medical University),Yukio Kobayashi(Department of Hematology, IUHW Mita Hospital)

Kentaro Fukushima1, Hirohiko Shibayama1, Sunggi Chi2, Seiichiro Katagiri3, Akihiko Gotoh3, Takanobu Morishita4, Takeshi Kondo5, Kazuhito Yamamoto6, Jyunya Kuroda7, Kensuke Usuki8, Yoshimitsu Makoto9, Kenji Ishitsuka9, Takaaki Ono10, Naoto Takahashi11, Satoshi Iyama12, Makoto Nakamura13, Yukinori Nakamura14, Koji Izutsu15, Junichiro Yuda2, Yosuke Minami2 (1.Deptartment of Hematology and Oncology, Osaka University, 2.Department of Hematology, National Cancer Center Hospital East, 3.Department of Hematology, Tokyo Medical University Hospital, 4.Div. Hematology, Japanese Red Cross Nagoya First Hospital, 5.Blood Disorders Center, Aiiku Hospital, 6.Department of Hematology/Cell Therapy, Aichi Cancer Center, 7.Division of Hematology/Oncology, Kyoto Prefectural University of Medicine, 8.Department of Hematology, NTT Medical Center Tokyo, 9.Department of Hematology, Kagoshima University Hospital, 10.Department of Hematology, Hamamatsu University Hospital, 11.Department of Hematology/Nephrology/Rheumatology, Akita University, 12.Department of Hematology, Sapporo Medical University, 13.Department of Hematology, Kochi University Hospital, 14.Department of Hematology, Yamaguchi University Hospital, 15.Department of Hematology, National Cancer Center Hospital)

Sunggi Chi1, Satoshi Uchiyama1, Makoto Yoshimitsu2, Kenji Ishitsuka2, Kaoru Yamamoto3, Yukinori Nakamura3, Takahashi Naoto11, Takeshi Kondo4, Kensuke Usuki5, Takaaki Ono6, Tsutomu Kobayashi7, Junya Kuroda7, Satoshi Iyama8, Makoto Nakamura9, Kensuke Kojima9, Suguru Fukuhara10, Koji Izutsu10, Nobuhiko Yamauchi1, Junichiro Yuda1, Yosuke Minami1 (1.Department of Hematology, National Cancer Center Hospital East, 2.Kagoshima University Hospital, 3.Yamaguchi University Hospital, 4.Blood Disorders Center, Aiiku Hospital, 5.Department of Hematology, NTT Medical Center Tokyo, 6.Department of Hematology, Hamamatsu University Hospital, 7.Division of Hematology and Oncology, Kyoto Prefectural University of Medicine, 8.Department of Hematology, Sapporo Medical University, 9.Department of Hematology, Kochi University Hospital, 10.Department of Hematology, National Cancer Center Hospital, 11.Akita University Graduate School of Medicine)

Hironori Arai1, Yoshikazu Utsu1, Shinichi Masuda1, Nobuyuki Aotsuka1, Seichiro Katagiri2, Akihiko Goto2, Motoki Eguchi3, Takanobu Morichita3, Reiki Ogasawara4, Takaaki Ono5, Naoto Takahashi6, Satoshi Iyama7, Makoto Nakamura8, Yukinori Nakamura9, Suguru Fukuhara10, Koji Izutsu10, Sunggi Chi11, Nobuhiko Yamauchi11, Junichiro Yuda11, Yosuke Minami11 (1.Div. of Hematology, Japanese Red Cross Narita Hospital, 2.Dept. of Hematology, Tokyo Medical University Hospital, 3.Div. Hematology, Japanese Red Cross Nagoya First Hospital, 4.Blood Disorders Center, Aiiku Hospital, 5.Dept. of Hematology, Hamamatsu University Hospital, 6.Dept. of Hematology/Nephrology/Rheumatology, Akita University, 7.Dept. of Hematology, Sapporo Medical University, 8.Dept. of Hematology, Kochi University Hospital, 9.Dept. of Hematology, Yamaguchi University Hospital, 10.Dept. of Hematology, National Cancer Center Hospital, Tokyo, Japan, 11.Dept. of Hematology, National Cancer Center Hospital East)

Takaaki Maekawa1,2, Tomoyuki Yoshikawa1, Miki Moriiwa1, Aoi Hirata1, Yukihiro Shimizu1, Hiraku Ogata2, Keita Saito2, Takuya Izumi2, Shigeki Nagao2, Kosuke Takano2, Yosuke Okada2, Noriaki Tachi2, Masahiro Teramoto2, Toshikuni Kawamura2, Toshikatsu Horiuchi2, Shoichiro Kato2, Ayako Kobayashi2, Shinichi Kobayashi2, Hiroyuki Kawaguchi1, Fumihiko Kimura2 (1.Department of Clinical Oncology, National Defense Medical College Hospital, 2.Division of Hematology, Department of Internal Medicine, National Defense Medical College)

Mamta P Sumi1, Sameer A Guru2, Imtiyaz A Najar3, Abdul R Mir4, Alpana Saxena5 (1.Department of Inflammation and immunity, Lerner Research Institute, Cleveland Clinic, Ohio, USA, 2.Department of Developmental and Systems Biology, Lurie Children's Hospital, Northwestern University, Chicago, Illinois, USA, 3.Central University of Kashmir, Srinagar, 4.Faculty of Applied Medical Sciences, University of Tabuk, Saudi Arabia, 5.Department of Biochemistry, Hamdard Institute of Medical Sciences and Research, New Delhi, India)

Sameer A Guru1, Mamta P Sumi2, Imtiyaz A Najar3, Abdul R Mir4, Alpna Saxena5 (1.Lurie Children's Hospital, Northwestern University, Chicago, USA, 2.Department of inflammation and Immunity, Cleveland Clinic, Ohio, USA, 3.Central University of Kashmir, Srinagar, 4.Faculty of Applied Medical Sciences, University of Tabuk, Saudi Arabia, 5.Department of Biochemistry, Hamdard Institute of Medical Sciences and Research, New Delhi, India)